Clinical trial
NADIM II: Neo-Adjuvant Immunotherapy
NCT03838159
Study timeline
Study start (actual)2019-05-15Date precision: day
Registry last updated2026-04-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
PaclitaxelDRUG · verified · RxNorm: paclitaxel
CarboplatinDRUG · verified · RxNorm: carboplatin
NivolumabDRUG · verified · RxNorm: nivolumab
Sponsors & collaborators
Fundación GECPlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03838159 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.